课题基金 / 基金详情

Clinical Core and Data Coordination Center

Clinical Core and Data Coordination Center
临床核心和数据协调中心
批准号:
8245839
负责人:
Daryl T Lau
金额:
$11.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Daryl T Lau的其他基金

相似基金

相关文献

中文摘要
翻译
丙型肝炎病毒是一个重大的公共卫生问题,其临床结果是可变的。宿主病毒相互作用
英文摘要
Hepatitis C virus is a significant public health issue and its clinical outcomes are variable. Host virus interactions play important roles in disease and treatment outcomes but the underlying Immunological mechanisms leading to spontaneous or treatment associated viral clearance are not welt understood. The studies proposed within this Hepatitis C Cooperative Research Center (HC CRC) application are focused on the innate immune mechanisms of HCV control. The proposed studies within all three projects Include both translational investigation using clinical specimens from patients with chronic hepatitis C, and in vitro expenments to evaluate mechanisms of HCV innate immune triggering, response, and infection control. These studies will rely on specialized human liver tissues, sera, plasma samples, and the associated clinical Information. Thus, we propose to establish a Clinical Core for service to all three projects in this HC CRC Program, The Liver Center at Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, is a major tertiary referral center in the Boston region and will be able to meet the requirements of the Clinical Core. The Clinical Core will serve as a central platform for the global studies in the U19 Program by providing clinical expertise and well characterized clinical specimens in support of investigating the hypotheses within each individual project of this HC CRC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core and Data Coordination Center
  • 批准号:
    7920499
  • 项目类别:
  • 资助金额:
    $12.37万
  • 财政年份:
    2010
  • 负责人:
    Daryl T Lau
  • 依托单位:
RACIAL DIFFERENCES IN IFN TRANSCRIPTIONAL RESPONSE
COMPARING THE RESPONSE RATE OF AN ACCELERATED VACCINATION SCHEDULE USING A
COMPARING THE RESPONSE RATE OF AN ACCELERATED VACCINATION SCHEDULE USING A
海外基金